Behavioral symptoms in dementia: community-based research.
Auer
S R
SR
Aging and Dementia Research Center, New York University Medical Center, New York, USA.
Monteiro
I M
IM
Reisberg
B
B
D000368:Aged; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D000553:Ambulatory Care; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003704:Dementia / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D004311:Double-Blind Method; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects / Q000627:therapeutic use; D005500:Follow-Up Studies; D015577:Geriatric Assessment; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008297:Male; D019965:Neurocognitive Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D012920:Social Behavior Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D013881:Thioridazine / Q000009:adverse effects / Q000627:therapeutic use
D014150:Antipsychotic Agents; D005473:Fluoxetine; D006220:Haloperidol; D017367:Selective Serotonin Reuptake Inhibitors; D013881:Thioridazine